What's actually in the vial? Half Year Laboratory Testing Summary
January – June 2026 · IPED Trends Series
Half Year Laboratory Summaries report the results of independent laboratory analysis of image and performance enhancing drug products submitted by consumers and purchased from the unregulated market. Each product is tested for what compound it actually contains and at what concentration, then compared against the seller's label, giving a six-monthly picture of how reliably labels on the Australian IPED market reflect what is in the vial.
Key Findings
Key Takeaways
- Only 12 of 26 products matched both the labelled compound and the labelled dose.
- 6 of 20 steroid vials held a steroid not named on the label.
- Three Retatrutide vials, all labelled 10 mg, ranged from 5.13 mg to 19 mg, one vial delivering close to four times another.
Recommended Citation
Akrigg K., Bonenti B., Craven A., Davey G., Ferris J., Kill E., Weith S., Piatkowski T. ROIDTrends Half Year Laboratory Testing Summary 2026, January 2026 – June 2026. IPED Trends Series. UQ, Queensland; 2026. DOI: https://doi.org/10.14264/8651cba
Funding
ROIDTrends is funded by the Queensland Mental Health Commission.
Copyright
This work is copyright. You may download, display, print and reproduce this material in unaltered form only (retaining this notice) for your personal, non-commercial use or use within your organisation. All other rights are reserved. Requests and enquiries concerning reproduction and rights should be addressed to the information manager.